A detailed history of Riverview Trust CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Riverview Trust CO holds 106 shares of CRL stock, worth $20,584. This represents 0.02% of its overall portfolio holdings.

Number of Shares
106
Previous 103 2.91%
Holding current value
$20,584
Previous $21,000 4.76%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$187.96 - $245.29 $563 - $735
3 Added 2.91%
106 $20,000
Q2 2024

Jul 16, 2024

SELL
$206.39 - $268.73 $54,693 - $71,213
-265 Reduced 72.01%
103 $21,000
Q1 2024

Apr 12, 2024

BUY
$203.52 - $273.43 $74,895 - $100,622
368 New
368 $99,000
Q2 2022

Jul 27, 2022

SELL
$204.13 - $302.4 $14,084 - $20,865
-69 Reduced 20.66%
265 $57,000
Q1 2022

Apr 21, 2022

BUY
$255.51 - $362.11 $17,630 - $24,985
69 Added 26.04%
334 $95,000
Q4 2018

Feb 12, 2019

BUY
$105.09 - $137.23 $27,848 - $36,365
265 New
265 $30,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.88B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.